Altshuler David

EVP, Chief Scientific Officer | EVP, Global Research And CSO

1 company

Average

Trades Analyzed

12M Win Rate

18.2%

Avg 3M Return

-3.8%

Avg 12M Return

-19.4%

Altshuler David is an EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 38 sells.

Estimated insider holdings value: $10.5M based on current market prices.

Holdings by Company

VRTXMay 15, 2025

Current Shares23.3K

Value$10.55M

Net Activity-170,244

Bought: 0Sold: 170.2K

Showing 10 filings (page 5)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
May 4, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sale+OE	2,330	$260.86	$607,803.01	-1.6%
Feb 25, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sell	3,028	$233.41	$706,775.76	-1.4%
Feb 18, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sell	3,128	$243.67	$762,200.76	-1.7%
Feb 11, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sell	17,032	$246.11	$4,191,771.36	-5.7%
Feb 6, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sale+OE	2,526	$239.42	$604,774.76	-0.9%
Feb 3, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sale+OE	4,126	$231.18	$953,861.49	-3.0%
Nov 25, 2019	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sale+OE	3,910	$219.37	$857,736.70	-11.0%
Nov 15, 2019	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sell	60	$205.95	$12,357.00	-0.2%
Nov 6, 2019	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sale+OE	1,223	$197.21	$241,189.04	-1.3%
Nov 4, 2019	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Global Research And CSO	Sale+OE	4,126	$200.45	$827,048.76	-6.1%